The present invention relates in general to pumping devices, and more specifically, to improved blood pumps with levitated impellers and methods for their control.
Mechanical circulatory support (MCS) devices are commonly used for treating patients with heart failure. One exemplary type of MCS device is a centrifugal flow blood pump. Many types of circulatory support devices are available for either short term or long term support for patients having cardiovascular disease. For example, a heart pump system known as a left ventricular assist device (LVAD) can provide long term patient support with an implantable pump associated with an externally-worn pump control unit and batteries. The LVAD improves circulation throughout the body by assisting the left side of the heart in pumping blood. Examples of LVAD systems are the DuraHeart® LVAS system made by Terumo Heart, Inc. of Ann Arbor, Mich. and the HeartMate II™ and HeartMate III™ systems made by Thoratec Corporation of Pleasanton, Calif. These systems typically employ a centrifugal pump with a magnetically levitated impeller to pump blood from the left ventricle to the aorta. The impeller is formed as the rotor of the electric motor and rotated by the rotating magnetic field from a multiphase stator such as a brushless DC motor (BLDC). The impeller is rotated to provide sufficient blood flow through the pump to the patient's systemic circulation.
Early LVAD systems utilized mechanical bearings such as ball-and-cup bearings. More recent LVADs employ non-contact bearings which levitate the impeller using hydrodynamic and/or magnetic forces. In one example, the impeller is levitated by the combination of hydrodynamic and passive magnetic forces.
There is a trend for making blood pumps more miniaturized to treat a broader patient population, more reliable, and with improved outcomes. To follow this trend, contactless impeller suspension technology has been developed in several pump designs. The principle of this technology is to levitate the pump impeller using one or a combination of forces from electromagnets, hydrodynamics, and permanent magnets. In the meanwhile, the pump should be hemocompatible to minimize the blood cell damage and blood clot formation. To that end, the bearing gap between the levitated impeller and the pump housing becomes an important factor. A small gap may lead to the high probability of the thrombus formation in the bearing or to elevated hemolysis due to excessive shear stress. Likewise, a large gap can compromise the hydrodynamic bearing performance and the pump efficiency.
One pump design utilizing active magnetic bearings achieves the desired bearing gap by levitating the impeller using magnetic fields generated by electromagnetic coils. However, in such a design there is the need for a separate bearing control system that includes the position sensors and electromagnetic coils to control the impeller position.
Another pump design levitates the impeller using hydrodynamic thrust bearings alone or combined with passive magnetic bearings. However, such a design usually requires a small bearing gap to provide sufficient hydrodynamic bearing stiffness to maintain impeller levitation and prevent contacts between impeller and the pump housing. Such a small gap may result in an insufficient washout and vulnerability to blood clotting thus compromising hemocompatibility.
Pumps utilizing hydrodynamic bearings to suspend the impeller are generally designed to maintain a generally constant gap through all operating conditions. A drawback of such designs is that the impeller starts to tilt when the pump flow rate increases. This impeller position shift under low pressure conditions across the narrow gap creates blood flow stasis, which in turn leads to thrombus formation on the bearing surfaces. One solution to solve the problem is to add a passive magnetic bearing to try to maintain a stable gap. However, the magnetic bearing solution increases the size of the pump and complexity of the system.
What is needed is a pump that addresses these and other problems of known designs. What is needed is a pump with a relatively small form factor and improved outcomes. What is needed is a pump that employs a simple bearing system and enhances blood flow gaps to reduce the risk of thrombus. What is needed is a solution to enhance the bearing gap to achieve adequate washout without increasing the complexity of the pump mechanical design or reducing the pump efficiency.
In summary, various aspects of the present invention are directed to a blood pump system including a pump housing; an impeller for rotating in a pump chamber within the housing; a stator comprising drive coils for applying a torque to the impeller; a bearing mechanism for suspending the impeller within the pump chamber; and a position control mechanism.
Various aspects of the invention are directed to a blood pump system including a pump housing; an impeller for rotating in a pump chamber within the housing; a stator comprising drive coils for applying a torque to the impeller; a first bearing for fixing the impeller relative to a first end of the pump chamber, a first blood gap defined between the impeller and a first bearing surface; a second bearing for fixing the impeller relative to a second end of the pump chamber, a second blood gap defined between the impeller and a second bearing surface; and a position control mechanism.
In various embodiments, the position control mechanism is configured to alternate the pump secondary flow gaps. In various embodiments, the position control mechanism is configured to move the impeller in an axial direction within the pump chamber to adjust a blood gap distance between the impeller and an opposing wall of the housing. In various embodiments, the position control mechanism is configured to move the impeller in an axial direction within the pump chamber to increase the first blood gap thereby increasing a washout rate.
In various embodiments, the washout rate is the average washout rate during a respective period of time. In various embodiments, the washout rate is the peak washout rate during a respective period of time. For example, the respective period of time may be the period during which the impeller is moved to a target position to increase the washout rate.
In various embodiments, the position control mechanism is configured to move the impeller periodically and intermittently. The position control mechanism may be configured to move the impeller for at least several seconds every minute. The position control mechanism may be configured to move the impeller based on a triggering event. The position control mechanism may be configured to move the impeller based on the impeller crossing a speed threshold. The speed threshold may be a low speed threshold. The triggering event may be based on a low speed threshold and time threshold.
In various embodiments, the pump is configured with at least a first balanced position with a narrow first gap and a second balanced position with a narrow second gap. The impeller may be controlled such that the impeller spends substantially equal amounts of time in the first and second balanced positions. In various embodiments, the amount of time the impeller spends in each balanced position is inversely proportional to the gap size. In various embodiments, one of the gaps is identified as being prone to stasis and the impeller spends more time in a position away from the identified gap.
In various embodiments, the movement of the impeller is asynchronous with the native heartbeat. In various embodiments, the movement of the impeller is synchronous with the native heartbeat.
In various embodiments, a total blood gap under normal operating conditions is 50 micrometers. In various embodiments, a total blood gap under normal operating conditions is 100 micrometers. In various embodiments, a total blood gap under normal operating conditions is 200 micrometers. In various embodiments, a total blood gap under normal operating conditions is 1000 micrometers. In various embodiments, a total blood gap under normal operating conditions is 2000 micrometers. In various embodiments, the impeller is moved to a position to decrease a respective blood gap by about 20%, by about 30%, by about 40%, by about 50%, by about 60%, by about 70%, by about 75%, by about 80%, or by about 90%.
Various aspects of the invention are directed to a method of operating a pump as described in any of the preceding paragraphs.
Various aspects of the invention are directed to a method of operating a blood pump including a housing and an impeller for rotating within a pump chamber within the housing including rotating the impeller within the pump chamber, the impeller being suspended within the pump chamber by a first bearing at a first end of the pump chamber and a second bearing at a second end of the pump chamber; and moving the impeller in an axial direction within the pump chamber to increase a first blood gap defined by the first bearing and to decrease a second blood gap defined by the second bearing.
Various aspects of the invention are directed to at least one system, method, or computer-program product as described in the specification and/or shown in any of the drawings.
In one aspect, a blood pump system is provided. The pump system may include a pump housing and an impeller for rotating in a pump chamber within the housing. The impeller may have a first side and a second side opposite the first side. The pump system may also include a stator having drive coils for applying a torque to the impeller and at least one bearing mechanism for suspending the impeller within the pump chamber. The pump system may further include a position control mechanism for moving the impeller in an axial direction within the pump chamber to adjust a size of a first gap and a size of a second gap, thereby controlling a washout rate at each of the first gap and the second gap. The first gap may be defined by a distance between the first side and the housing and the second gap is defined by a distance between the second side and the pump housing.
In another aspect, a blood pump system may include a pump housing, an impeller for rotating in a pump chamber within the housing, and a stator having drive coils for applying a torque to the impeller. The pump system may also include a first bearing for fixing the impeller relative to a first end of the pump chamber. A first blood gap may be defined between the impeller and a first bearing surface. The pump system may further include a second bearing for fixing the impeller relative to a second end of the pump chamber. A second blood gap may be defined between the impeller and a second bearing surface. The pump system may include a position control mechanism for moving the impeller in an axial direction within the pump chamber to increase the first blood gap thereby increasing a washout rate at the first blood gap.
In another aspect, a method is provided of operating a blood pump including a housing and an impeller for rotating within a pump chamber within the housing. The method may include rotating the impeller within the pump chamber. The impeller may be suspended within the pump chamber by a first bearing at a first end of the pump chamber and a second bearing at a second end of the pump chamber. The method may also include moving the impeller in an axial direction within the pump chamber to increase a first blood gap defined by the first bearing and to decrease a second blood gap defined by the second bearing.
The structures and methods of the present invention have other features and advantages which will be apparent from or are set forth in more detail in the accompanying drawings, which are incorporated in and form a part of this specification, and the following Detailed Description of the Invention, which together serve to explain the principles of the present invention.
Reference will now be made in detail to the preferred embodiments of the invention, examples of which are illustrated in the accompanying drawings. While the invention will be described in conjunction with the preferred embodiments, it will be understood that they are not intended to limit the invention to those embodiments. On the contrary, the invention is intended to cover alternatives, modifications and equivalents, which may be included within the spirit and scope of the invention as defined by the appended claims.
For convenience in explanation and accurate definition in the appended claims, the terms “up” or “upper”, “down” or “lower”, “inside” and “outside” are used to describe features of the present invention with reference to the positions of such features as displayed in the figures.
In many respects the modifications of the various figures resemble those of preceding modifications and the same reference numerals followed by subscripts “a”, “b”, “c”, and “d” designate corresponding parts.
As used herein, “gap” generally refers to the secondary flow gaps around the impeller as would be understood by one of skill in the art. The primary flow is through the impeller blade regions. The secondary flow gaps are the other areas of fluid, generally around the impeller. In some respects, the secondary flow gaps are between the impeller and the housing wall and define the hydrodynamic bearing.
The term “machine-readable medium” includes, but is not limited to portable or fixed storage devices, optical storage devices, wireless channels and various other mediums capable of storing, containing or carrying instructions and/or data. A code segment or machine-executable instructions may represent a procedure, a function, a subprogram, a program, a routine, a subroutine, a module, a software package, a class, or any combination of instructions, data structures, or program statements. A code segment may be coupled to another code segment or a hardware circuit by passing and/or receiving information, data, arguments, parameters, or memory contents. Information, arguments, parameters, data, etc. may be passed, forwarded, or transmitted via any suitable means including memory sharing, message passing, token passing, network transmission, etc.
Furthermore, embodiments of the invention may be implemented, at least in part, either manually or automatically. Manual or automatic implementations may be executed, or at least assisted, through the use of machines, hardware, software, firmware, middleware, microcode, hardware description languages, or any combination thereof. When implemented in software, firmware, middleware or microcode, the program code or code segments to perform the necessary tasks may be stored in a machine readable medium. One or more processors may perform the necessary tasks.
Although aspects of the invention will be described with reference to a blood pump, one will appreciate that the invention can be applied to other types of pumps. The mechanisms and methods of the invention will be described in relation to blood pumps and in particular the ability to adjust the impeller operating position to address performance, such as the attendant risks for thrombus and hemolysis when pumping blood. One will appreciate from the description herein that the invention can be applied broadly to other pumps, rotary machines, and induction motors.
Turning to the drawings, aspects of the invention enable to the ability to enhance or control the bearing gaps. One might wish to increase the bearing gap to adjust the washout rate, lubricate the bearing surfaces, or remove materials (particulates, thrombus, etc.) from the bearing gap. Another use of the invention may be to increase pump efficiency. As is known in the art, the motor efficiency increases as the impeller magnet moves closer to the motor drive coils. Another use of the invention may be to correct impeller malpositioning due to bulk forces or external forces (e.g. bumps or movements of the patient's body). These and other advantages can be achieved without the need for complex control systems in accordance with the invention.
Various aspects of the invention are directed to improving the washout in a respective pump bearing gap by moving the impeller to a position to increase the respective gap size. The impeller may be moved periodically (e.g. by time) or triggered by an event. When the impeller moves up, the larger gap on the bottom of the pump leads to a higher flow rate, which in turn leads to a higher washout rate. The upward movement of the impeller may also “squeeze” the blood above the impeller in a sort of pumping action, which also increases the washout rate. The fluid above is squeezed as the impeller moves, but once the impeller is in the new position the pumping effect is lost whereas the higher washout rate still remains below at the larger gap. In other words, the pumping effect on washout rate occurs at a specific point in time whereas the larger gap effect is temporal in nature. The basic concept makes use of the fact that the gap size is correlated to the washout rate. The washout rate relates to an average time for a full exchange of fluid. Accordingly, if the gap size divided by the washout rate is equal to a few seconds that doesn't necessarily mean the impeller should move for only a few seconds. Oftentimes, the impeller is moved for between about 100%, 120%, 150%, 200%, or other percentage of the average time for full exchange calculated by the gap size divided by the washout rate to have higher confidence. The washout flow rate is generally proportional to the cube of the gap width. Therefore, theoretically the total washout flow rate will be 8 times greater when the gap becomes 2 times wider. See W. K. Chan et al., Analytical Investigation of Leakage Flow I Disk Clearance of Magnetic Suspended Centrifugal Impeller, Artificial Organ (2000). Washout rate is vital, as a failure to get full washout may result in thrombosis formation in areas of stasis or where fluid isn't exchanged. This creates two risks: 1) the thrombus may dislodge and flow into the body, thus causing an embolism (or a stroke depending on where it goes), and 2) the thrombus may continue unabated, causing the activated site to form more platelets, which in turn provide a site for thrombin to adhere.
Accordingly, alternating the gaps has been found to improve the hydrodynamic bearing washout while maintaining a small total gap (good pump efficiency, proper HD bearing operations, etc.). In other words, alternating the gaps improves the washout without increasing the total gap.
The above technique can be implemented in a pump with a hydrodynamic and/or electromagnetic bearing. With a hydrodynamic bearing design, it is expected that there will be power loss associated with movement of the impeller. In one embodiment using electromagnets and hydrodynamic pressure grooves, the power loss can be minimized by designing the bearing stiffness curve to have at least two stable (eccentric) positions and facilitating movement of the impeller between these at least two positions. In one example, the electromagnets need additional force only to move the impeller from one side to another, and no such force is required to keep the impeller on one side.
In one embodiment, an electromagnetic force control method is used to change the impeller position and enhance the effective gap between the impeller and the blood chamber. The technique uses the same pump motor stator coils adjust the impeller position as is used to apply a torque to the impeller. No additional control subsystems and components are necessary.
Turning now to the drawings, wherein like components are designated by like reference numerals throughout the various figures, attention is directed to
A typical cardiac assist system includes a pumping unit, drive electronics, microprocessor control unit, and an energy source such as rechargeable batteries and/or an AC power conditioning circuit. The system is implanted during a surgical procedure in which a centrifugal pump is placed in the patient's chest. An inflow conduit is pierced into the left ventricle to supply blood to the pump. One end of an outflow conduit is mechanically fitted to the pump outlet and the other end is surgically attached to the patient's aorta by anastomosis. A percutaneous cable connects to the pump, exits the patient through an incision, and connects to the external control unit.
Various aspects of the implantable pump are similar to those shown and described in U.S. Pat. Nos. 4,528,485; 4,857,781; 5,229,693; 5,588,812; 5,708,346; 5,917,297; 6,100,618; 6,222,290; 6,249,067; 6,268,675; 6,355,998; 6,351,048; 6,365,996; 6,522,093; 7,972,122; and 8,686,674; and U.S. Pub. No. 2014/0205467 and 2012/0095281, the entire contents of which patents and publications are incorporated herein by this reference for all purposes.
The exemplary system utilizes an implantable pump with contactless bearings for supporting the impeller. Contactless bearings (i.e., levitation) provide a number of potential benefits. Because they reduce rotational friction, theoretically they improve motor efficiency and reduce the risk of introducing particulates into the fluid. In one example, the impeller employs upper and lower plates having magnetic materials (the terminology of upper and lower being arbitrary since the pump can be operated in any orientation). A stationary magnetic field from the upper side of the pump housing attracts the upper plate and a rotating magnetic field from the lower side of the pump housing attracts the lower plate. The forces cooperate so that the impeller rotates at a levitated position within the pumping chamber. Features (not shown) may also be formed in the walls of the pumping chamber to produce a hydrodynamic bearing wherein forces from the circulating fluid also tend to center the impeller. Hydrodynamic pressure grooves adapted to provide such a hydrodynamic bearing are shown in U.S. Pat. No. 7,470,246, issued Dec. 30, 2008, titled “Centrifugal Blood Pump Apparatus,” which is incorporated herein for all purposes by reference.
The exemplary impeller has an optimal location within the pumping chamber with a predetermined spacing from the chamber walls on each side. Maintaining a proper spacing limits the shear stress and the flow stasis of the pump. A high shear stress can cause hemolysis of the blood (i.e., damage to cells). Flow stasis can cause thrombosis (i.e., blood clotting).
With continued reference to
In various embodiments, the commutator circuit and/or various electronics may be on the implanted side of the system. For example, various electronics may be positioned on-board the pump or in a separate hermetically sealed housing. Among the potential advantages of implanting electronics is the ability to control the pump even when communication is lost with the control unit 15 outside the body.
As one will understand from the description above, however, the balanced position is not necessarily a specific, static location. The hydrodynamic forces on the impeller will change as the rotational speed of the impeller changes. In turn, the magnetic attractive forces on the impeller will change as the impeller moves closer to or away from the magnet structure 34 and stator assembly 35. Accordingly, the impeller generally finds a new balanced position as the rotational speed changes. As will be described below, however, aspects of the invention are directed to moving the impeller or changing the balanced position for each given rotational speed. For example, the impeller position control mechanisms to be described facilitate moving the impeller axially (up or down) without changing the rotational speed and all other. This has the effect of enabling movement of the impeller independent of rotor speed. An advantage of this technique is that rotor speed can be determined in normal course (e.g. by a physician based on the patient's physiological needs) without concern for changing the impeller position. Conversely, the impeller position can be changed without affecting pumping throughput.
In one embodiment, the impeller position is controlled using vector motor control. Several structures and techniques for modifying impeller position using vector motor control will now be described with reference to
FaΣ=Fhdb+Fpin+Fem
Where,
FaΣ is the combined force to levitate the impeller
Fhdb is the combination of hydrodynamic forces from the inlet side bearing, the motor side bearing, or both
Fpin is the combination of permanent magnet attraction forces
Fem is the magnetic attraction force generated from the motor.
When the impeller is stabilized, FaΣ should be equal to zero. Usually Fem can be controlled through the electronic system to adjust the impeller position since all the others are the fixed configurations as the passive mode. Therefore, the basic design concept of this invention is to apply the motor vector control (FOC) to control the force Fem so that the impeller position can be adjusted while rotating only using one set of motor coil and drive system. In such way, there is no additional cost in the pump structure.
In various respects, the washout rate refers to the average washout rate during a respective period of time. In various respects, the washout rate refers to the peak washout rate. The respective period of time may be any designated period of time, for example, the period during which the impeller is moved to a target position to increase the washout rate.
The trigger may be temporal-based or event-based. In various embodiments, the position control mechanism is configured to move the impeller periodically and intermittently. In other words, the trigger can be the passage of a predetermined amount of time and/or based on a set frequency and cycle. In one example, the position control mechanism is configured to move the impeller for at least several seconds every minute. In various embodiments, the position control mechanism is configured to move the impeller based on the impeller crossing a speed threshold. The speed threshold may be a low speed threshold. The trigger may be based on a low speed threshold and time threshold. For example, the impeller may be moved after it spends more than a set amount of time at a low speed. This may be beneficial because low speeds can lead to touchdown events, stasis, and other issues. Thus, the impeller may be moved to ensure any particulates or thrombus are cleared from the gap.
In various embodiments, the pump is configured with at least a first balanced position with a narrow first gap and a second balanced position with a narrow second gap. As compared to
The impeller may be controlled such that the impeller spends substantially equal amounts of time in the first and second balanced positions. This may be useful where the pump is otherwise designed for the impeller to normally be in a centered position, such as shown in
In various embodiments, the movement of the impeller is asynchronous with the native heartbeat. In various embodiments, the movement of the impeller is synchronous with the native heartbeat.
In various embodiments, a total blood gap under normal operating conditions is 50 micrometers. In various embodiments, a total blood gap under normal operating conditions is 100 micrometers. In various embodiments, a total blood gap under normal operating conditions is 200 micrometers. In various embodiments, a total blood gap under normal operating conditions is 1000 micrometers. In various embodiments, a total blood gap under normal operating conditions is 2000 micrometers. In various embodiments, the impeller is moved to a position to decrease a respective blood gap by about 20%, by about 30%, by about 40%, by about 50%, by about 60%, by about 70%, by about 75%, by about 80%, or by about 90%.
One will appreciate that
Mechanical or contact bearings exhibit little to no movement regardless of the rotational speed and other factors. Nonetheless, contact bearings demonstrate some operational movement even if such movement requires precise instruments to be measured. Many types of blood pumps, for example, utilize bearings which are washed and lubricated by an external source. Examples of a pump with a blood-immersed bearing are described in U.S. Pub. No. 2012/0095281 and U.S. Pat. No. 5,588,812, incorporated herein for all purposes by reference. In one example, a pump includes blood immersed contact bearings such as a ball-and-cup. In one example, the bearings are washed and/or lubricated by saline or infusate. The use of saline is a common scenario for percutaneous pumps because they have a fluidic connection to sources outside the body. Examples of percutaneous pumps with contact bearings are disclosed in U.S. Pat. Nos. 7,393,181 and 8,535,211, incorporated herein by reference for all purposes. As will be appreciated by one of skill in the art, contact bearings which are designed to have a fluid at least periodically washing between the contact surface will have some movement. Although this movement is small relative to non-contact bearings (e.g. on the order of 5, 10, 20, 100 or more times smaller), they are subject to some degree of movement.
Conventional thinking is that a blood pump (e.g. left ventricular assist device) should be designed to maintain a stable impeller position and consistent blood gaps across the device lifetime. In blood pumps, in particular, movement of the impeller is often associated with hemolysis and other undesirable risks. There is a belief that decreasing a pump gap creates a region of stasis which leads to thrombus and other adverse events.
However, it has been found that adjusting the pump gap in a controlled and designed manner can actually improve performance and outcomes. Various aspects of the invention are directed to pumps configured to actively and purposefully modify the impeller position. In one embodiment, the balanced position of the impeller is changed during operation.
There are several potential benefits to the technique described above for moving the impeller and alternating the pump gaps. One of these potential benefits is the ability to increase the peak washout flow velocity. Another potential benefit is the ability to prevent or reduce the collection of ingested thrombus in narrow gaps without increasing the total gap size. In turn, pump efficiency and performance are not compromised. Existing solutions (e.g. stable-gap hydrodynamic bearing designs) rely on the native heart to change the blood flow pattern in the narrow gap areas (such as systole/diastole). The inventive technique is advantageous because it actively changes the flow pattern independently of the native heart function, impeller speed, etc. Also, many heart failure patients have weakened native hearts with insufficient pulsatility to actually wash out the bearing gaps. With the inventive technique, the combination of the external pressure change and internal geometry change (rotor position change) will minimize the blood flow stasis which causes pump thrombosis.
At any particular combination of the (1) magnitude of the phase current and (2) the speed of the impeller, modifying the Id current for generating the phase voltages can change the attractive force generated by the stator thereby affecting the impeller balance. In turn, the impeller moves until it settles at a new balanced position where the hydrodynamic forces and magnetic forces are balanced. In this manner, the impeller can be moved simply by adjustments to the motor control signal.
In accordance with the invention, Id current is utilized to control the impeller position by enhancing or weakening the magnetic flux between impeller (rotor) and motor stator coils to adjust the attraction force Fem. This in turn changes the impeller position (shown in
In one embodiment, the impeller position control technique is implemented as an open loop control without impeller position sensors. In one embodiment, impeller position control technique is implemented as a closed loop control with impeller position sensors.
In order to ensure proper positioning, active monitoring and control of the impeller position has been employed in the exemplary embodiment by adjusting the stationary magnetic field. However, position sensors and an adjustable magnetic source occupy a significant amount of space and add to the complexity of a system. Accordingly, the use of sensors may depend on the design requirements. Suitable sensors may include, but are not limited to, Hall-effect sensors, variable reluctance sensors, and accelerometers.
In one embodiment using the open loop control, the impeller is controlled by periodically alternating the position from one side to another (e.g. from inlet side to motor side) by modulating the Id current as shown in
With continued reference to
The exemplary system differs from conventional configurations inasmuch as the FOC block and electronics are configured to alter the field oriented control algorithm so that the Id current can be varied independently to generated the required attractive force. The exemplary system potentially sacrifices such efficiency in return for other benefits. Among the benefits of the exemplary system is the ability to independently control the impeller position.
Turning to
Impeller 210 is fixed within the housing by ball-and-cup bearings 212 and 214. The ball-and-cup bearings are closely toleranced and generally fix the impeller in a specific position. However, the exemplary bearings are lubricated and washed by the blood flow around the impeller. Accordingly, there is some fluid between the ball and cup surfaces.
Torque is applied to the impeller by a stator assembly 205. The stator assembly 205 includes windings and is driven using a FOC algorithm in a similar manner to the stator assemblies described above. In practice, the impeller position is adjusted proceeding according to the method shown in
The method of adjusting the pump gaps to increase the washout rate may be particularly beneficial in pump designs with mechanical bearings. The relatively small gaps in the bearings mean that there is very little fluid flow and thus a higher risk of thrombus. The greater friction also can contribute to greater thrombus risk. Accordingly, the ability to increase the gap between the ball and the cup, even on a small scale, can lead to significant improvements in outcomes.
Impeller 411 is stabilized in the pump chamber by a combination of hydrodynamic and passive magnetic forces. Impeller 411, which is a magnetic material, interacts with the magnetic material in stator assembly 405 to provide an axial centering force. A pump ring 452 with a chamfer surface is positioned at the leading end of the impeller to create hydrodynamic stabilization forces in the axial direction (left to right) and radial direction (up and down on page). A permanent magnet ring 450 is provided at the trailing edge of the impeller is oriented with a north pole facing a north pole of the impeller. This arrangement creates an axial bias force to push the impeller against the pump ring 452. The magnet ring 450 also provides a radially centering force. Finally, the impeller includes deep hydrodynamic grooves to generate a hydrodynamic pressure force against the inner walls of the pump chamber for radial stabilization.
In operation, the impeller remains stable in the axial and radial directions. There may be some axial movement as the rotational speed of the impeller changes or as a result of other forces (e.g. the native pulse), but generally the impeller remains centered below the stator assembly.
Using the FOC control technique described above, the attractive force of the stator assembly 405 on impeller 411 can be modified. In one embodiment, pump 400 is configured so impeller is eccentric when centered below the stator assembly 405. In this example, increasing the attractive force amounts to an increase in the axial stiffness to resist axial movement. In one embodiment, the attractive force is modified to actually move impeller 411 axially. For example, the impeller can be moved closer to pump ring 452 to squeeze blood out of the gap between impeller 411 and a surface of ring 452. The impeller may also be moved away from ring 452 to increase the blood gap therebetween. In this manner, the impeller position control technique adds an element of active position control otherwise not possible with the passive bearing configuration of pump 400.
The foregoing descriptions of specific embodiments of the present invention have been presented for purposes of illustration and description. They are not intended to be exhaustive or to limit the invention to the precise forms disclosed, and obviously many modifications and variations are possible in light of the above teaching. The embodiments were chosen and described in order to best explain the principles of the invention and its practical application, to thereby enable others skilled in the art to best utilize the invention and various embodiments with various modifications as are suited to the particular use contemplated. It is intended that the scope of the invention be defined by the Claims appended hereto and their equivalents.
This application is a continuation of U.S. patent application Ser. No. 16/443,471, filed on Jun. 17, 2019 and entitled “ALTERNATING PUMP GAPS”, which is a continuation of U.S. patent application Ser. No. 15/041,987, filed Feb. 11, 2016 and entitled “ALTERNATING PUMP GAPS”, which claims priority to U.S. Provisional Application No. 62/115,318, filed Feb. 12, 2015 and entitled “ALTERNATING PUMP GAPS”, which are hereby incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
1093868 | Leighty | Apr 1914 | A |
2684035 | Kemp | Jul 1954 | A |
3023334 | Burr et al. | Feb 1962 | A |
3510229 | Smith | May 1970 | A |
3620638 | Kaye et al. | Nov 1971 | A |
3870382 | Reinhoudt | Mar 1975 | A |
3932069 | Giardini et al. | Jan 1976 | A |
3960468 | Boorse et al. | Jun 1976 | A |
4149535 | Voider | Apr 1979 | A |
4382199 | Isaacson | May 1983 | A |
4392836 | Sugawara | Jul 1983 | A |
4434389 | Langley et al. | Feb 1984 | A |
4507048 | Belenger et al. | Mar 1985 | A |
4528485 | Boyd, Jr. | Jul 1985 | A |
4540402 | Aigner | Sep 1985 | A |
4549860 | Yakich | Oct 1985 | A |
4645961 | Maisky | Feb 1987 | A |
4686982 | Nash | Aug 1987 | A |
4688998 | Olsen et al. | Aug 1987 | A |
4753221 | Kensey et al. | Jun 1988 | A |
4763032 | Bramm | Aug 1988 | A |
4769006 | Papatonakos | Sep 1988 | A |
4779614 | Moise | Oct 1988 | A |
4790843 | Carpentier et al. | Dec 1988 | A |
4806080 | Mizobuchi et al. | Feb 1989 | A |
4814677 | Plunkett | Mar 1989 | A |
4817586 | Wampler | Apr 1989 | A |
4846152 | Wampler et al. | Jul 1989 | A |
4857781 | Shih | Aug 1989 | A |
4888011 | Kung et al. | Dec 1989 | A |
4895557 | Moise et al. | Jan 1990 | A |
4900227 | Trouplin | Feb 1990 | A |
4902272 | Milder et al. | Feb 1990 | A |
4906229 | Wampler | Mar 1990 | A |
4908012 | Moise et al. | Mar 1990 | A |
4919647 | Nash | Apr 1990 | A |
4930997 | Bennett | Jun 1990 | A |
4944722 | Carriker et al. | Jul 1990 | A |
4957504 | Chardack | Sep 1990 | A |
4964864 | Summers et al. | Oct 1990 | A |
4969865 | Hwang et al. | Nov 1990 | A |
4985014 | Orejola | Jan 1991 | A |
4995857 | Arnold | Feb 1991 | A |
5021048 | Buckholtz | Jun 1991 | A |
5078741 | Bramm et al. | Jan 1992 | A |
5092844 | Schwartz et al. | Mar 1992 | A |
5092879 | Jarvik | Mar 1992 | A |
5100374 | Kageyama | Mar 1992 | A |
5106263 | Irie | Apr 1992 | A |
5106273 | Lemarquand et al. | Apr 1992 | A |
5106372 | Ranford | Apr 1992 | A |
5112202 | Ozaki et al. | May 1992 | A |
5129883 | Black | Jul 1992 | A |
5145333 | Smith | Sep 1992 | A |
5147186 | Buckholtz | Sep 1992 | A |
5112349 | Summers et al. | Dec 1992 | A |
5190528 | Fonger et al. | Feb 1993 | A |
5201679 | Velte et al. | Apr 1993 | A |
5211546 | Isaacson et al. | May 1993 | A |
5229693 | Futami et al. | Jul 1993 | A |
5275580 | Yamazaki | Jan 1994 | A |
5290227 | Pasque | Jan 1994 | A |
5290236 | Mathewson | Mar 1994 | A |
5300112 | Barr | Apr 1994 | A |
5306295 | Kolff et al. | Apr 1994 | A |
5312341 | Turi | May 1994 | A |
5313128 | Robinson et al. | May 1994 | A |
5332374 | Kricker et al. | Jul 1994 | A |
5346458 | Afield | Sep 1994 | A |
5350283 | Nakazeki et al. | Sep 1994 | A |
5354331 | Schachar | Nov 1994 | A |
5360445 | Goldowsky | Nov 1994 | A |
5370509 | Golding et al. | Dec 1994 | A |
5376114 | Jarvik | Dec 1994 | A |
5385581 | Bramm et al. | Jan 1995 | A |
5405383 | Barr | Nov 1995 | A |
5449342 | Hirose et al. | Dec 1995 | A |
5478222 | Heidelberg et al. | Dec 1995 | A |
5504978 | Meyer, III | Apr 1996 | A |
5507629 | Jarvik | Apr 1996 | A |
5519270 | Yamada et al. | May 1996 | A |
5533957 | Aldea | Sep 1996 | A |
5569111 | Cho et al. | Oct 1996 | A |
5575630 | Nakazawa et al. | Nov 1996 | A |
5588812 | Taylor et al. | Dec 1996 | A |
5595762 | Derrieu et al. | Jan 1997 | A |
5643226 | Cosgrove et al. | Jan 1997 | A |
5611679 | Ghosh et al. | Mar 1997 | A |
5613935 | Jarvik | Mar 1997 | A |
5678306 | Bozeman, Jr. et al. | Oct 1997 | A |
5692882 | Bozeman, Jr. et al. | Dec 1997 | A |
5695471 | Wampler | Dec 1997 | A |
5708346 | Schob | Jan 1998 | A |
5725357 | Nakazeki et al. | Mar 1998 | A |
5738649 | Macoviak | Apr 1998 | A |
5746575 | Westphal et al. | May 1998 | A |
5746709 | Rom et al. | May 1998 | A |
5755784 | Jarvik | May 1998 | A |
5776111 | Tesio | Jul 1998 | A |
5795074 | Rahman et al. | Aug 1998 | A |
5800559 | Higham et al. | Sep 1998 | A |
5807311 | Palestrant | Sep 1998 | A |
5814011 | Corace | Sep 1998 | A |
5824069 | Lemole | Oct 1998 | A |
5749855 | Reitan | Dec 1998 | A |
5843129 | Larson et al. | Dec 1998 | A |
5851174 | Jarvik et al. | Dec 1998 | A |
5853394 | Tolkoff et al. | Dec 1998 | A |
5890883 | Golding et al. | Apr 1999 | A |
5911685 | Siess et al. | Jun 1999 | A |
5917295 | Mongeau | Jun 1999 | A |
5917297 | Gerster et al. | Jun 1999 | A |
5921913 | Siess | Jul 1999 | A |
5924848 | Izraelev | Jul 1999 | A |
5924975 | Goldowsky | Jul 1999 | A |
5928131 | Prem | Jul 1999 | A |
5938412 | Israelev | Aug 1999 | A |
5941813 | Sievers et al. | Aug 1999 | A |
5945753 | Maegaw et al. | Aug 1999 | A |
5868702 | Stevens et al. | Sep 1999 | A |
5868703 | Bertolero et al. | Sep 1999 | A |
5947703 | Nojiri et al. | Sep 1999 | A |
5951263 | Taylor et al. | Sep 1999 | A |
5984892 | Bedingham | Nov 1999 | A |
5964694 | Siess et al. | Dec 1999 | A |
6004269 | Crowley et al. | Dec 1999 | A |
6007479 | Rottenberg et al. | Dec 1999 | A |
6030188 | Nojiri et al. | Feb 2000 | A |
6042347 | Scholl et al. | Mar 2000 | A |
6053705 | Schob et al. | Apr 2000 | A |
6066086 | Antaki et al. | May 2000 | A |
6071093 | Hart | Jun 2000 | A |
6074180 | Khanwilkar et al. | Jun 2000 | A |
6080133 | Wampler | Jun 2000 | A |
6082900 | Takeuchi et al. | Jul 2000 | A |
6083260 | Aboul-Hosn et al. | Jul 2000 | A |
6100618 | Schoeb et al. | Aug 2000 | A |
6058593 | Siess | Sep 2000 | A |
6123659 | leBlanc et al. | Sep 2000 | A |
6123726 | Mori et al. | Sep 2000 | A |
6139487 | Siess | Oct 2000 | A |
6086527 | Talpade | Nov 2000 | A |
6142752 | Akamatsu et al. | Nov 2000 | A |
6143025 | Stobie et al. | Nov 2000 | A |
6146325 | Lewis et al. | Nov 2000 | A |
6149683 | Lancisi et al. | Nov 2000 | A |
6158984 | Cao et al. | Dec 2000 | A |
6171078 | Schob | Jan 2001 | B1 |
6176822 | Nix et al. | Jan 2001 | B1 |
6176848 | Rau et al. | Jan 2001 | B1 |
6179773 | Prem et al. | Jan 2001 | B1 |
6190304 | Downey et al. | Feb 2001 | B1 |
6200260 | Bolling | Mar 2001 | B1 |
6206659 | Izraelev | Mar 2001 | B1 |
6254359 | Aber | Mar 2001 | B1 |
6222290 | Schob et al. | Apr 2001 | B1 |
6227797 | Watterson et al. | May 2001 | B1 |
6227820 | Jarvik | May 2001 | B1 |
6234772 | Wampler et al. | May 2001 | B1 |
6234998 | Wampler | May 2001 | B1 |
6247892 | Kazatchkov et al. | Jun 2001 | B1 |
6249067 | Schob et al. | Jun 2001 | B1 |
6264635 | Wampler et al. | Jul 2001 | B1 |
6268675 | Amrhein | Jul 2001 | B1 |
6276831 | Takahashi et al. | Aug 2001 | B1 |
6293901 | Prem | Sep 2001 | B1 |
6295877 | Aboul-Hosn et al. | Oct 2001 | B1 |
6319231 | Andrulitis | Nov 2001 | B1 |
6320731 | Eeaves et al. | Nov 2001 | B1 |
6245007 | Bedingham et al. | Dec 2001 | B1 |
6351048 | Schob et al. | Feb 2002 | B1 |
6355998 | Schob et al. | Mar 2002 | B1 |
6365996 | Schob | Apr 2002 | B2 |
6375607 | Prem | Apr 2002 | B1 |
6387037 | Bolling et al. | May 2002 | B1 |
6394769 | Bearnson et al. | May 2002 | B1 |
6422990 | Prem | Jul 2002 | B1 |
6425007 | Messinger | Jul 2002 | B1 |
6428464 | Bolling | Aug 2002 | B1 |
6439845 | Veres | Aug 2002 | B1 |
6447266 | Antaki et al. | Sep 2002 | B2 |
6447441 | Yu et al. | Sep 2002 | B1 |
6458163 | Slemker et al. | Oct 2002 | B1 |
6508777 | Macoviak et al. | Jan 2003 | B1 |
6508787 | Erbel et al. | Jan 2003 | B2 |
6517315 | Belady | Feb 2003 | B2 |
6522093 | Hsu et al. | Feb 2003 | B1 |
6532964 | Aboul-Hosn et al. | Mar 2003 | B2 |
6533716 | Schmitz-Rode et al. | Mar 2003 | B1 |
6544216 | Sammler et al. | Apr 2003 | B1 |
6547519 | deBlanc et al. | Apr 2003 | B2 |
6547530 | Ozaki et al. | Apr 2003 | B2 |
6575717 | Ozaki et al. | Jun 2003 | B2 |
6589030 | Ozaki | Jul 2003 | B2 |
6595762 | Khanwilkar et al. | Jul 2003 | B2 |
6605032 | Benkowski et al. | Aug 2003 | B2 |
6609883 | Woodard et al. | Aug 2003 | B2 |
6610004 | Viole et al. | Aug 2003 | B2 |
6623420 | Reich et al. | Sep 2003 | B2 |
6641378 | Davis et al. | Nov 2003 | B2 |
6641558 | Aboul-Hosn et al. | Nov 2003 | B1 |
6688861 | Wampler | Feb 2004 | B2 |
6692318 | McBride | Feb 2004 | B2 |
6698097 | Miura et al. | Mar 2004 | B1 |
6709418 | Aboul-Hosn et al. | Mar 2004 | B1 |
6716157 | Goldowsky | Apr 2004 | B2 |
6716189 | Jarvik et al. | Apr 2004 | B1 |
6732501 | Yu et al. | May 2004 | B2 |
6749598 | Keren et al. | Jun 2004 | B1 |
6776578 | Belady | Aug 2004 | B2 |
6790171 | Griindeman et al. | Sep 2004 | B1 |
6794789 | Siess et al. | Sep 2004 | B2 |
6808371 | Niwatsukino et al. | Oct 2004 | B2 |
6817836 | Nose et al. | Nov 2004 | B2 |
6846168 | Davis et al. | Jan 2005 | B2 |
6860713 | Hoover | Jan 2005 | B2 |
6884210 | Nose et al. | Apr 2005 | B2 |
6935344 | Aboul-Hosn et al. | Aug 2005 | B1 |
6926662 | Aboul-Hosn et al. | Sep 2005 | B1 |
6942672 | Heilman et al. | Sep 2005 | B2 |
6949066 | Beamson et al. | Sep 2005 | B2 |
6966748 | Woodard et al. | Nov 2005 | B2 |
6974436 | Aboul-Hosn et al. | Dec 2005 | B1 |
6991595 | Burke et al. | Jan 2006 | B2 |
7010954 | Siess et al. | Mar 2006 | B2 |
7011620 | Siess | Mar 2006 | B1 |
7022100 | Aboul-Hosn et al. | Apr 2006 | B1 |
7048681 | Tsubouchi et al. | May 2006 | B2 |
7089059 | Pless | Aug 2006 | B1 |
7090401 | Rahman et al. | Aug 2006 | B2 |
7112903 | Schob | Sep 2006 | B1 |
7122019 | Kesten et al. | Oct 2006 | B1 |
7128538 | Tsubouchi et al. | Oct 2006 | B2 |
7027875 | Siess et al. | Nov 2006 | B2 |
7156802 | Woodard et al. | Jan 2007 | B2 |
7160243 | Medvedev | Jan 2007 | B2 |
7175588 | Morello | Feb 2007 | B2 |
7202582 | Eckert et al. | Apr 2007 | B2 |
7172551 | Leasure | Jun 2007 | B2 |
7241257 | Ainsworth et al. | Oct 2007 | B1 |
7284956 | Nose et al. | Oct 2007 | B2 |
7331921 | Viole et al. | Feb 2008 | B2 |
7335192 | Keren et al. | Feb 2008 | B2 |
7393181 | McBride et al. | Jul 2008 | B2 |
7431688 | Wampler et al. | Oct 2008 | B2 |
7329236 | Kesten et al. | Dec 2008 | B2 |
7462019 | Allarie et al. | Dec 2008 | B1 |
7467930 | Ozaki et al. | Dec 2008 | B2 |
7470246 | Mori et al. | Dec 2008 | B2 |
7476077 | Woodard et al. | Jan 2009 | B2 |
7491163 | Viole et al. | Feb 2009 | B2 |
7575423 | Wampler | Aug 2009 | B2 |
7645225 | Medvedev et al. | Jan 2010 | B2 |
7660635 | Verness et al. | Feb 2010 | B1 |
7699586 | LaRose et al. | Apr 2010 | B2 |
7748964 | Yaegashi et al. | Jul 2010 | B2 |
7731675 | Aboul-Hosn et al. | Aug 2010 | B2 |
7802966 | Wampler et al. | Sep 2010 | B2 |
7841976 | McBride et al. | Nov 2010 | B2 |
7862501 | Woodard | Jan 2011 | B2 |
7888242 | Tanaka et al. | Feb 2011 | B2 |
7934909 | Nuesser et al. | May 2011 | B2 |
7972122 | LaRose et al. | Jul 2011 | B2 |
7976271 | LaRose et al. | Jul 2011 | B2 |
7997854 | LaRose et al. | Aug 2011 | B2 |
8007254 | LaRose et al. | Aug 2011 | B2 |
8096935 | Sutton et al. | Jan 2012 | B2 |
8123669 | Siess et al. | Feb 2012 | B2 |
8152493 | LaRose et al. | Apr 2012 | B2 |
8177703 | Smith et al. | May 2012 | B2 |
8226373 | Yaehashi | Jul 2012 | B2 |
8282359 | Ayre et al. | Oct 2012 | B2 |
8283829 | Yamamoto et al. | Oct 2012 | B2 |
8366381 | Woodard et al. | Feb 2013 | B2 |
8403823 | Yu et al. | Mar 2013 | B2 |
8512012 | Mustafa et al. | Aug 2013 | B2 |
8535211 | Campbell et al. | Sep 2013 | B2 |
8585290 | Bauer | Nov 2013 | B2 |
8686674 | Bi et al. | Apr 2014 | B2 |
8770945 | Ozaki et al. | Jul 2014 | B2 |
8821365 | Ozaki et al. | Sep 2014 | B2 |
8827661 | Mori | Sep 2014 | B2 |
8652024 | Yanai et al. | Oct 2014 | B1 |
8864644 | Yomtov | Oct 2014 | B2 |
8870552 | Ayre et al. | Oct 2014 | B2 |
8968174 | Yanai et al. | Mar 2015 | B2 |
9039595 | Ayre et al. | May 2015 | B2 |
9067005 | Ozaki et al. | Jun 2015 | B2 |
9068572 | Ozaki et al. | Jun 2015 | B2 |
9109601 | Mori | Aug 2015 | B2 |
9132215 | Ozaki et al. | Sep 2015 | B2 |
9133854 | Okawa et al. | Sep 2015 | B2 |
9371826 | Yanai et al. | Jun 2016 | B2 |
9381285 | Ozaki et al. | Jul 2016 | B2 |
9382908 | Ozaki et al. | Jul 2016 | B2 |
9410549 | Ozaki et al. | Aug 2016 | B2 |
9556873 | Yanai et al. | Jan 2017 | B2 |
10371152 | Yanai et al. | Jul 2019 | B2 |
11015605 | Yanai et al. | May 2021 | B2 |
20010039369 | Terentiev | Nov 2001 | A1 |
20020051711 | Ozaki | May 2002 | A1 |
20020058994 | Hill et al. | May 2002 | A1 |
20020094281 | Khanwilkar et al. | Jul 2002 | A1 |
20020095210 | Finnegan et al. | Jul 2002 | A1 |
20030023302 | Moe et al. | Jan 2003 | A1 |
20030045772 | Reich et al. | Mar 2003 | A1 |
20030072656 | Niwatsukino et al. | Apr 2003 | A1 |
20030144574 | Heilman et al. | Jul 2003 | A1 |
20030163019 | Goldowsky | Aug 2003 | A1 |
20030199727 | Burke | Oct 2003 | A1 |
20030236488 | Novak | Dec 2003 | A1 |
20030236490 | Novak | Dec 2003 | A1 |
20040007515 | Geyer | Jan 2004 | A1 |
20040015232 | Shu et al. | Jan 2004 | A1 |
20040024285 | Muckter | Feb 2004 | A1 |
20040030381 | Shu | Feb 2004 | A1 |
20040064012 | Yanai | Apr 2004 | A1 |
20040143151 | Mori et al. | Jul 2004 | A1 |
20040145337 | Morishita | Jul 2004 | A1 |
20040152944 | Medvedev et al. | Aug 2004 | A1 |
20040171905 | Yu et al. | Sep 2004 | A1 |
20040210305 | Shu et al. | Oct 2004 | A1 |
20040215050 | Morello | Oct 2004 | A1 |
20040263341 | Enzinna | Dec 2004 | A1 |
20050004418 | Morello | Jan 2005 | A1 |
20050008496 | Tsubouchi et al. | Jan 2005 | A1 |
20050025630 | Ayre et al. | Feb 2005 | A1 |
20050043665 | Vinci et al. | Feb 2005 | A1 |
20050073273 | Maslov et al. | Apr 2005 | A1 |
20050089422 | Ozaki et al. | Apr 2005 | A1 |
20050131271 | Benkowski et al. | Jun 2005 | A1 |
20050141887 | Lelkes | Jun 2005 | A1 |
20050194851 | Eckert et al. | Sep 2005 | A1 |
20050261542 | Abe et al. | Nov 2005 | A1 |
20050287022 | Yaegashi et al. | Dec 2005 | A1 |
20060024182 | Akdis et al. | Feb 2006 | A1 |
20060055274 | Kim | Mar 2006 | A1 |
20060127227 | Mehlhorn et al. | Jun 2006 | A1 |
20070073393 | Kung et al. | Mar 2007 | A1 |
20070078293 | Shambaugh, Jr. | Apr 2007 | A1 |
20070095648 | Wampler et al. | Apr 2007 | A1 |
20070114961 | Schwarzkopf | May 2007 | A1 |
20070134993 | Tamez et al. | Jun 2007 | A1 |
20070189648 | Kita et al. | Aug 2007 | A1 |
20070213690 | Phillips et al. | Sep 2007 | A1 |
20070231135 | Wampler et al. | Oct 2007 | A1 |
20070253842 | Horvath et al. | Nov 2007 | A1 |
20070282298 | Mason | Dec 2007 | A1 |
20070297923 | Tada | Dec 2007 | A1 |
20080007196 | Tan et al. | Jan 2008 | A1 |
20080021394 | La Rose et al. | Jan 2008 | A1 |
20080030895 | Obara et al. | Feb 2008 | A1 |
20080119777 | Vinci et al. | May 2008 | A1 |
20080124231 | Yaegashi | May 2008 | A1 |
20080183287 | Ayre | Jul 2008 | A1 |
20080211439 | Yokota et al. | Sep 2008 | A1 |
20080281146 | Morello | Nov 2008 | A1 |
20090041595 | Garzaniti et al. | Feb 2009 | A1 |
20090060743 | McBride et al. | Mar 2009 | A1 |
20090074336 | Engesser et al. | Mar 2009 | A1 |
20090099406 | Salmonsen et al. | Apr 2009 | A1 |
20090171136 | Shambaugh, Jr. | Jul 2009 | A1 |
20090257693 | Aiello | Oct 2009 | A1 |
20090318834 | Fujiwara et al. | Dec 2009 | A1 |
20100185280 | Ayre et al. | Jun 2010 | A1 |
20100168534 | Matsumoto et al. | Jul 2010 | A1 |
20100222634 | Poirier | Sep 2010 | A1 |
20100234835 | Horikaw et al. | Sep 2010 | A1 |
20100256440 | Maher | Oct 2010 | A1 |
20100262039 | Fujiw et al. | Oct 2010 | A1 |
20100266423 | Gohean et al. | Oct 2010 | A1 |
20100305692 | Thomas et al. | Dec 2010 | A1 |
20100324465 | Vinci et al. | Dec 2010 | A1 |
20110015732 | Kanebako | Jan 2011 | A1 |
20110112354 | Nishimura et al. | May 2011 | A1 |
20110118766 | Reichenbach et al. | May 2011 | A1 |
20110118829 | Hoarau et al. | May 2011 | A1 |
20110118833 | Reichenbach et al. | May 2011 | A1 |
20110129373 | Mori | Jun 2011 | A1 |
20110160519 | Arndt et al. | Jun 2011 | A1 |
20110218383 | Broen et al. | Sep 2011 | A1 |
20110218384 | Bachman et al. | Sep 2011 | A1 |
20110218385 | Bolyare et al. | Sep 2011 | A1 |
20110237978 | Fujiwara et al. | Sep 2011 | A1 |
20110243759 | Ozaki | Oct 2011 | A1 |
20110318203 | Ozaki et al. | Dec 2011 | A1 |
20120003108 | Ozaki et al. | Jan 2012 | A1 |
20120016178 | Woodard et al. | Jan 2012 | A1 |
20120022645 | Burke | Jan 2012 | A1 |
20120035411 | LaRose et al. | Feb 2012 | A1 |
20120078030 | Bourque | Mar 2012 | A1 |
20120078031 | Burke et al. | Mar 2012 | A1 |
20120095280 | Timms | Apr 2012 | A1 |
20120095281 | Reichenbach et al. | Apr 2012 | A1 |
20120130152 | Ozaki et al. | May 2012 | A1 |
20120226350 | Ruder et al. | Sep 2012 | A1 |
20120243759 | Fujisawa | Sep 2012 | A1 |
20120245681 | Casas et al. | Sep 2012 | A1 |
20120253103 | Jarvik | Oct 2012 | A1 |
20120308363 | Ozaki et al. | Dec 2012 | A1 |
20130030240 | Schima et al. | Jan 2013 | A1 |
20130121821 | Ozaki et al. | May 2013 | A1 |
20130158521 | Sobue | Jun 2013 | A1 |
20130170970 | Ozaki et al. | Jul 2013 | A1 |
20130178694 | Jeffery et al. | Jul 2013 | A1 |
20130225909 | Dormanen et al. | Aug 2013 | A1 |
20130243623 | Okawa et al. | Sep 2013 | A1 |
20130289334 | Badstibner et al. | Oct 2013 | A1 |
20130331711 | Mathur et al. | Dec 2013 | A1 |
20140030122 | Ozaki et al. | Jan 2014 | A1 |
20140066690 | Siebenhaar et al. | Mar 2014 | A1 |
20140066691 | Siebenhaar | Mar 2014 | A1 |
20140100413 | Casas et al. | Apr 2014 | A1 |
20140107399 | Spence | Apr 2014 | A1 |
20140142367 | Ayre et al. | May 2014 | A1 |
20140155682 | Jeffery et al. | Jun 2014 | A1 |
20140200389 | Yanai et al. | Jul 2014 | A1 |
20140205467 | Yanai et al. | Jul 2014 | A1 |
20140241904 | Yanai et al. | Aug 2014 | A1 |
20140275721 | Yanai et al. | Sep 2014 | A1 |
20140275727 | Bonde et al. | Sep 2014 | A1 |
20140296615 | Franano | Oct 2014 | A1 |
20140309481 | Medvedev et al. | Oct 2014 | A1 |
20140314597 | Allaire et al. | Oct 2014 | A1 |
20140323796 | Medvedev et al. | Oct 2014 | A1 |
20140343352 | Ardt et al. | Nov 2014 | A1 |
20150017030 | Ozaki | Jan 2015 | A1 |
20150023803 | Fritz et al. | Jan 2015 | A1 |
20150078936 | Mori | Mar 2015 | A1 |
20150306290 | Rosenberg et al. | Oct 2015 | A1 |
20150367048 | Brown et al. | Dec 2015 | A1 |
20150374892 | Yanai et al. | Dec 2015 | A1 |
20160058929 | Medvedev et al. | Mar 2016 | A1 |
20160058930 | Medvedev et al. | Mar 2016 | A1 |
20160228628 | Medvedev et al. | Aug 2016 | A1 |
20160235899 | Yu et al. | Aug 2016 | A1 |
20160235900 | Yanai et al. | Aug 2016 | A1 |
20160281720 | Yanai et al. | Sep 2016 | A1 |
20160281728 | Ozaki et al. | Sep 2016 | A1 |
Number | Date | Country |
---|---|---|
1347585 | May 2002 | CN |
1462344 | Dec 2003 | CN |
102239334 | Nov 2011 | CN |
102341600 | Feb 2012 | CN |
2945662 | Sep 1999 | EP |
971212 | Jan 2000 | EP |
1113117 | Jul 2001 | EP |
1327455 | Jul 2003 | EP |
1430919 | Jun 2004 | EP |
1598087 | Mar 2005 | EP |
1526286 | Apr 2005 | EP |
1495773 | Nov 2006 | EP |
2292282 | Mar 2011 | EP |
2298375 | Mar 2011 | EP |
2372160 | Oct 2011 | EP |
2405140 | Jan 2012 | EP |
2405141 | Jan 2012 | EP |
2461465 | Jun 2012 | EP |
2538086 | Dec 2012 | EP |
2554191 | Feb 2013 | EP |
2594799 | May 2013 | EP |
2618001 | Jul 2013 | EP |
2693609 | Feb 2014 | EP |
2948202 | Dec 2015 | EP |
2961987 | Jan 2016 | EP |
3013385 | May 2016 | EP |
58-9535 | Jan 1983 | JP |
61-293146 | Dec 1986 | JP |
H02-007780 | Jan 1990 | JP |
H02-033590 | Mar 1990 | JP |
04-091396 | Mar 1992 | JP |
04-148094 | May 1992 | JP |
05-021197 | Mar 1993 | JP |
06-014538 | Feb 1994 | JP |
06-053790 | Jul 1994 | JP |
2006-070476 | Sep 1994 | JP |
2006-245455 | Sep 1994 | JP |
07-014220 | Mar 1995 | JP |
07-042869 | Aug 1995 | JP |
07-509156 | Oct 1995 | JP |
09-122228 | May 1997 | JP |
10-331841 | Dec 1998 | JP |
11-244377 | Sep 1999 | JP |
H11-241695 | Sep 1999 | JP |
2001-309628 | Nov 2001 | JP |
2002303288 | Oct 2002 | JP |
2003-501155 | Jan 2003 | JP |
2003-135592 | May 2003 | JP |
2004-166401 | Jun 2004 | JP |
2004-209240 | Jul 2004 | JP |
2004-332566 | Nov 2004 | JP |
2004-346925 | Dec 2004 | JP |
2005-094955 | Apr 2005 | JP |
2005-127222 | May 2005 | JP |
2005-245138 | Sep 2005 | JP |
2005-270345 | Oct 2005 | JP |
2005-270415 | Oct 2005 | JP |
2005-287599 | Oct 2005 | JP |
2006-167173 | Jun 2006 | JP |
2007-002885 | Jan 2007 | JP |
2007-043821 | Feb 2007 | JP |
2007-089972 | Apr 2007 | JP |
2007-089974 | Apr 2007 | JP |
2007-215292 | Aug 2007 | JP |
2007-247489 | Sep 2007 | JP |
2008-011611 | Jan 2008 | JP |
2008-104278 | May 2008 | JP |
2008-132131 | Jun 2008 | JP |
2008-99453 | Aug 2008 | JP |
2008-193838 | Aug 2008 | JP |
2008-297997 | Dec 2008 | JP |
2008-301634 | Dec 2008 | JP |
2006-254619 | Sep 2009 | JP |
2010-133381 | Jun 2010 | JP |
2010-136863 | Jun 2010 | JP |
2010-203398 | Sep 2010 | JP |
2010-209691 | Sep 2010 | JP |
2010-261394 | Nov 2010 | JP |
2011-169166 | Sep 2011 | JP |
2012-021413 | Feb 2012 | JP |
2012-062790 | Mar 2012 | JP |
5171953 | Mar 2013 | JP |
5572832 | Aug 2014 | JP |
5656835 | Jan 2015 | JP |
1993-07388 | Apr 1993 | WO |
94-14226 | Jun 1994 | WO |
1996-31934 | Oct 1996 | WO |
1997-42413 | Nov 1997 | WO |
2000-64509 | Nov 2000 | WO |
2004-098677 | Nov 2004 | WO |
2005-011087 | Feb 2005 | WO |
2005-028000 | Mar 2005 | WO |
2005-034312 | Apr 2005 | WO |
2006-053384 | May 2006 | WO |
2009-157408 | Dec 2009 | WO |
2010-067682 | Jun 2010 | WO |
2010-101082 | Sep 2010 | WO |
2010-101107 | Sep 2010 | WO |
2011-013483 | Feb 2011 | WO |
2012-036059 | Mar 2012 | WO |
2012-040544 | Mar 2012 | WO |
2012-047550 | Apr 2012 | WO |
2012-132850 | Oct 2012 | WO |
2014-113533 | Jul 2014 | WO |
2014-116676 | Jul 2014 | WO |
2014-133942 | Sep 2014 | WO |
2014-179271 | Nov 2014 | WO |
2016-033131 | Mar 2016 | WO |
2016-033133 | Mar 2016 | WO |
2016-130846 | Aug 2016 | WO |
2016-130944 | Aug 2016 | WO |
2016-130989 | Aug 2016 | WO |
Entry |
---|
Terumo Heart, Inc., Handled With Care—Significantly Reduce the Risk of Cell Damage, Terumo brochure, Apr. 2010, 2 pages. |
Asama, J., et al., A Compact Highly Efficient and LowHemolytic Centrifugal Blood Pump With a Magnetically Levitated Impeller,Artificial Organs, vol. 30, No. 3, Mar. 1, 2006 (Mar. 1, 2006), pp. 160-167. |
Asama, J., et al., A New Design for a Compact Centrifugal Blood Pump with a Magnetically Levitated Rotor, Asaio Jopurnal, vol. 50, No. 6, Nov. 1, 2004 (Nov. 1, 2004 ), pp. 550-556. |
Asama, et al., Suspension Performance of a Two-Axis Actively Regulated Consequent-Pole Bearingless Motor, IEEE Transactions on Energy Conversion, vol. 28, No. 4, Dec. 2013, 8 pages. |
Gifras, et al., Advancements in Electric Machines, publisher, Springer, Nov. 14, 2008, pp. 43-48. |
Kosaka, et al., Operating Point Control System for a Continuous FlowArtificial Heart: In Vitro Study, ASAIO Journal 2003, 6 pages. |
Neethu, S., et al., Novel design, optimization and realization of axial flux motor for implantable blood pump, Power Bectronics, Drives and Energy Systems (PEDES) & 2010 Power Indian, 2010 Joint International Conference on, IEEE, Dec. 20, 2010 (Dec. 20, 2010), pp. 1-6. |
Sandtner, J., et al., Electrodynamic Passive Magnetic Bearing with Planar Halbach Arrays, Ninth International Symposium on Magnetic Bearings, Aug. 3-6, 2004, 6 pages. |
Yamazaki, et al., Development of a Miniature Intraventricular Axial FlowBlood Pump, ASAIO Journal, Jul.-Sep. 1993, pp. M224-M230. |
European Search report Issued in European Patent Application No. 10748702.7, dated Apr. 2, 2013, all pages. |
Extended European Search Report issued in European Patent Application No. EP 10748677.1, dated Nov. 19, 2012, all pages. |
Extended European Search Report dated Jun. 18, 2015 in in European Patent Application No. 11825062.0, all pages. |
Extended European Search Report issued in European Patent Application No. EP 11806627.3, dated Oct. 8, 2014, all pages. |
Extended European Search Report dated Apr. 2, 2015 in European Patent Application No. EP 09770118.9 filed Jun. 22, 2009, all pages. |
International Search Report (PCT-ISA-210) dated Jul. 14, 2009, by Japanese Patent Office as the International Searching Authority for International Application No. PCT-JP2009-061318, all pages. |
International Search Report and Written Opinion issued in PCT-JP2011-050925, dated Apr. 12, 2011, all pages. |
International Search Report and Written Opinion issued in PCT-JP2011-054134, dated Apr. 12, 2011, all pages. |
International Search Report and Written Opinion issued in PCT-JP2011-064768, dated Sep. 13, 2011, all pages. |
International Search Report and Written Opinion issued in PCT-JP2011-070450, dated Dec. 13, 2011, all pages. |
International Search Report and Written Opinion of PCT-US2014-012448 dated Feb. 19, 2014, all pages. |
International Search Report and Written Opinion of PCT-US2014-011786 dated May 5, 2014, all pages. |
International Search Report and Written Opinion of PCT-US2014-012502 dated May 9, 2014, all pages. |
International Search Report and Written Opinion of PCT-US2014-012511 dated May 14, 2014, all pages. |
International Preliminary Report on Patentability dated Aug. 6, 2015 for International Patent Application No. PCT-US2014-012511 filed Jan. 22, 2014, all pages. |
International Preliminary Report on Patentability dated Aug. 6, 2015 for International Patent Application No. PCT-US2014-012502 filed Jan. 22, 2014, all pages. |
International Preliminary Report on Patentability dated Feb. 25, 2016 for International Patent Application No. PCT-US2014-035798 filed Apr. 29, 2014, all pages. |
Supplementary European Search Report issued in European Application No. 09831788.6, dated Jan. 7, 2013, 7 pages. |
European office action dated Jan. 27, 2016 for EP 10804230.0, all pages. |
Extended European Search Report dated Feb. 4, 2016 in.European Patent Application No. EP 12764433.4, filed Mar. 12, 2012, all pages. |
International Preliminary Report on Patentability dated Jul. 30, 2015 for International Patent Application No. PCT/US2014/011786, filed Jan. 16, 2014, all pages. |
International Search Report and Written Opinion of PCT/US2014/017932, dated Jun. 16, 2014, all pages. |
International Preliminary Report on Patentability dated Sep. 11, 2015 for International Patent Application No. PCT/US2014/017932, filed Feb. 24, 2014, all pages. |
International Search Report and Written Opinion of PCT/US2014/035798, dated Feb. 11, 2016, all pages. |
International Search Report and Written Opinion of PCT/US2016/017611, dated May 16, 2016, all pages. |
International Search Report and Written Opinion of PCT/US2016/017791, dated May 16, 2016, all pages. |
Japanese office action dated Dec. 11, 2015 JP 2013-507344, all pages. |
International Search Report and Written Opinion of PCT/US2016/017812, dated Jun. 7, 2016, all pages. |
International Search Report and Written Opinion of PCT/US2016/017864, dated Jun. 8, 2016, all pages. |
Decision to Grant for JP 2013-507344 dated Jun. 14, 2016, all pages. |
Notice of Reasons for Refusal dated Jul. 14, 2020 in Japanese Patent Application No. 2017-542484 8 pages. |
International Search Report and Written Opinion of PCT/US2015/046844, dated Oct. 27, 2015, all pages. |
International Search Report and Written Opinion of PCT/US2015/046846, dated Oct. 27, 2015, all pages. |
European office action dated Jul. 22, 2016 for European Patent Application No. EP 09770118.9 all pages. |
European office action dated Sep. 8, 2016 for EP 14741174, all pages. |
Extended European Search Report for EP 14743371, dated Sep. 29, 2016, all pages. |
European office action dated Oct. 31, 2016 for EP 10804230.0, all pages. |
European Office Action issued in Application No. EP 11825062, dated Jul. 19, 2016, all pages. |
International Search Report and Written Opinion of PCT/US2016/062284, dated Feb. 24, 2017, all pages. |
Extended European Search Report dated Jul. 30, 2018 in European Patent Application No. 16749989.6, all pages. |
U.S. Appl. No. 15/041,987 received a Non Final Office Action dated May 18, 2017, 16 pages. |
U.S. Appl. No. 15/041,987 received a Final Office Action dated Oct. 19, 2017, 18 pages. |
U.S. Appl. No. 15/041,987 received a Non Final Office Action dated Mar. 21, 2018, 118 pages. |
U.S. Appl. No. 15/041,987 received a Final Office Action dated Aug. 14, 2018, 20 pages. |
U.S. Appl. No. 15/041,987 received a Notice of Allowance dated Mar. 18, 2019, 13 pages. |
U.S. Appl. No. 16/443,471 received a Non-Final Office Action dated Sep. 11, 2020, 19 pages. |
U.S. Appl. No. 16/443,471 received a Notice of Allowance dated Jan. 22, 2021, 8 pages. |
Number | Date | Country | |
---|---|---|---|
20210246902 A1 | Aug 2021 | US |
Number | Date | Country | |
---|---|---|---|
62115318 | Feb 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16443471 | Jun 2019 | US |
Child | 17240204 | US | |
Parent | 15041987 | Feb 2016 | US |
Child | 16443471 | US |